pipette
ENEnglish

Inpatient Mortality and Risk Factors Among Hospitalized Medicare Beneficiaries Ages 65 and Older with COVID-19 Treated with COVID-19 Convalescent Plasma (CCP), During 2020-2021

M. Menis, N. Duma, S. Barney, Y. Chillarige, W. R. Steele, S. H. Chang, C. H. Villa, A. F. Eder, B. I. Whitaker

PreprintUso en el mundo real

En palabras de los autores

Background: COVID-19 has had a substantial burden on older adults aged 65+. The study objective was to evaluate inpatient mortality among hospitalized Fee-for-Service (FFS) Medicare beneficiaries ages 65+ with COVID-19 treated with COVID-19 convalescent plasma (CCP) during August 2020-December 2021: overall, monthly, and by patient and hospital characteristics. Study Design and Methods: Our retrospective claims-based study utilized large Centers for Medicare & Medicaid Services administrative databases to assess inpatient COVID-19 stays with recorded CCP transfusions among FFS Medicare beneficiaries ages 65+. CCP transfusions were identified by recorded procedure codes, and inpatient mortality via the patient status discharge code. Crude inpatient mortality rates (per 100 CCP transfusion stays with COVID-19) and corresponding 95% confidence intervals were evaluated across a range of patient and hospital characteristics. Multivariate logistic regression analyses were used to assess potential risk factors. Results: The overall crude inpatient mortality was 25.5% (95%CI:25.2%-25.8%), declining from 30.7% (95%CI:29.1%-32.3%) in August 2020 to 7.4% (95%CI:3.8%-15.0%) in December 2021, p<0.001. The study identified significantly higher adjusted odds of inpatient mortality for each year of advancing age (1.06; 95%CI:1.06-1.07), immunocompromised (IC) vs. non-IC (1.14; 95%CI:1.05-1.24), males vs. females (1.20; 95%CI:1.15-1.25), Medicaid-eligible vs. not (1.13; 95%CI:1.07-1.20), medium (1.14; 95%CI:1.06-1.22) and large (1.09; 95%CI:1.01-1.19) compared to small hospitals, with ICU/CCU admission vs. not (2.71; 95%CI:2.57-2.85), mechanical ventilation<96 hours (13.11; 95%CI:12.11-14.20) and [&ge;]96 hours (11.59; 95%CI:10.89-12.34) vs. not, among others. Discussion: The findings highlight importance of patient and hospital characteristics, including demographics, comorbidities, socioeconomic status, and COVID-19 severity, for inpatient mortality among Medicare beneficiaries receiving CCP.

Resultado principalEl resumen no menciona limitaciones.

Apareció: martes, 27 de octubre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.22.26365943